drug · small molecule
patient view →remibrutinib
Marketedupdated 2mo agoby $NVS NOVARTIS AG🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for immune system disease and 5 investigational indications.
all catalysts(1)
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that